DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,168,990 | +2.9% | 8,742 | -0.5% | 0.18% | +3.4% |
Q2 2023 | $2,107,949 | -3.7% | 8,783 | +1.1% | 0.17% | -15.5% |
Q1 2023 | $2,189,121 | -1.1% | 8,686 | +4.1% | 0.21% | -9.3% |
Q4 2022 | $2,213,939 | +3.3% | 8,341 | +0.5% | 0.23% | -8.8% |
Q3 2022 | $2,144,000 | +3.3% | 8,300 | +1.3% | 0.25% | +6.9% |
Q2 2022 | $2,076,000 | -11.7% | 8,190 | +2.2% | 0.23% | +2.6% |
Q1 2022 | $2,351,000 | -9.2% | 8,013 | +1.8% | 0.23% | -7.3% |
Q4 2021 | $2,589,000 | +33.1% | 7,868 | +8.6% | 0.24% | +17.2% |
Q3 2021 | $1,945,000 | 0.0% | 7,246 | 0.0% | 0.21% | 0.0% |
Q2 2021 | $1,945,000 | +20.4% | 7,246 | +1.0% | 0.21% | +14.2% |
Q1 2021 | $1,615,000 | +3.2% | 7,175 | +1.8% | 0.18% | -5.7% |
Q4 2020 | $1,565,000 | +5.9% | 7,045 | +2.6% | 0.19% | -3.0% |
Q3 2020 | $1,478,000 | +18.2% | 6,867 | -2.9% | 0.20% | +8.7% |
Q2 2020 | $1,250,000 | +24.3% | 7,069 | -2.7% | 0.18% | -8.5% |
Q1 2020 | $1,006,000 | -11.8% | 7,267 | -2.2% | 0.20% | +0.5% |
Q4 2019 | $1,141,000 | +6.3% | 7,432 | +0.0% | 0.20% | -4.8% |
Q3 2019 | $1,073,000 | +1.0% | 7,431 | 0.0% | 0.21% | -4.5% |
Q2 2019 | $1,062,000 | +3.9% | 7,431 | -4.0% | 0.22% | +4.8% |
Q1 2019 | $1,022,000 | +35.9% | 7,741 | +6.1% | 0.21% | +14.8% |
Q4 2018 | $752,000 | -12.9% | 7,299 | -7.6% | 0.18% | +14.4% |
Q3 2018 | $863,000 | +10.8% | 7,897 | -0.1% | 0.16% | +2.6% |
Q2 2018 | $779,000 | +11.1% | 7,902 | +8.2% | 0.16% | -25.0% |
Q1 2018 | $701,000 | +3.2% | 7,300 | +2.7% | 0.21% | +6.7% |
Q4 2017 | $679,000 | +7.3% | 7,110 | -2.1% | 0.20% | -4.9% |
Q3 2017 | $633,000 | +16.8% | 7,260 | +10.2% | 0.20% | +9.0% |
Q2 2017 | $542,000 | -5.1% | 6,587 | -0.7% | 0.19% | -13.8% |
Q1 2017 | $571,000 | +45.7% | 6,632 | +36.1% | 0.22% | +29.0% |
Q4 2016 | $392,000 | – | 4,874 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |